Credentials & Testimonials
“FairJourney Biologics was founded by a group of scientists that have a significant track record in generating therapeutic antibodies to industry standards. They have consistently impressed us with their speed and expertise.”
Mark ThrosbyCase studies
The expertise, capacity and skills of FairJourney Biologics team is illustrated in several case studies that can be consulted here
News & Events
Triple Vector for Discovery of Antibody Molecules in Full Therapeutic Format
FairJourney Biologics’ CSO Maria Pajuelo will make a presentation about Triple Vector for Discovery of Antibody Molecules in Full Therapeutic Format, at the 9th annual of PEGS Europe – Protein & Antibody Engineering Summit, on Tuesday, 14th of November 2017, at 2:55pm, in Lisbon, Portugal.
BioPharm America 2017 (26-27 September)
FairJourney Biologics will be attending BioPharm America 2017, that will take place on 26-27 September 2017, in Boston, United States.
Attendee:
António Parada
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
FairJourney Biologics co-authors a Nature Medicine paper entitled: A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels. Nat Med. 2017 Aug 21. doi: 10.1038/nm.4390.
(https://www.ncbi.nlm.nih.gov/pubmed/28825717)
Rua do Campo Alegre 823
4150-180 Porto
PORTUGAL
T : +351 222 437 510
Email : info@fjb.pt
© Copyright 2015 FairJourney Biologics
